Sitemap

November 03, 2022 Articles

Filter by Available Specialty
  1. ‘Mind-blowing’ weight loss with semaglutide extends to adolescents with obesity
  2. Assessing chemical exposures key to understanding neuro diseases and disorders
  3. Berdazimer gel safe, tolerable with minimal systemic exposure in molluscum contagiosum
  4. BLOG: Trials, tribulations of recruiting Black patients for cancer research
  5. Both in-person, virtual interventions yielded clinical improvement of hip, knee OA
  6. CDC updates clinical guidance on prescribing opioids for pain
  7. Clinical evaluation of opioid use disorder treatment funded by $5.6M NIH grant
  8. Diabetic macular edema treatment promising at 24 weeks in phase 2 study
  9. Exclusion of race may lead to classification of living kidney donor as having CKD
  10. FDA approves cobimetinib for histiocytic neoplasms
  11. FDA approves expanded use of Dupixent pre-filled pens in young children
  12. FDA clears at-home screening tool to assess risk for lung, liver disease linked to alpha-1
  13. FDA expands Vemlidy approval for chronic HBV in children aged older than 12 years
  14. Genetic variants linked to inherited cardiomyopathies; disease penetrance remains low
  15. Healio Minute Podcast, Neurology Edition: Top Headlines - Week of October 31, 2022
  16. Higher smoking intensity linked with reduced optic nerve vessel density in glaucoma
  17. HIV seroconversions tied to poor PrEP adherence
  18. Infants who breastfeed for shorter duration more likely to have obesity during childhood
  19. Intravascular lithotripsy improves stenosis in real-world cohort of calcified PAD
  20. Location of anaphylaxis episode influences epinephrine use in children
  21. Mania associated with lower dopamine transporter density in bipolar patients
  22. Midlife LGBTQ women report better sexual function vs. heterosexual women
  23. More adipose tissue increases breast cancer risk after menopause
  24. Older cancer survivors at higher risk for bone fracture
  25. Overlaps in shrimp, house dust mite allergies drive respiratory, other symptoms
  26. Patient motivation key to gluten-free diet adherence, improved mental health outcomes
  27. President of ASN: The time for a nephrology movement is now
  28. Primary endpoints met in Vabysmo phase 3 studies for retinal vein occlusion
  29. PROMISE II: Deep venous arterialization boosts amputation-free survival in severe CLI
  30. Psilocybin studies may lead to ‘revolutionary’ shift in cancer-related depression treatment
  31. Q&A: Trial to assess phage therapy in patients with cystic fibrosis
  32. Redo ablation for AF improves symptom burden, quality of life
  33. Regular exercise may enhance effectiveness of COVID-19 vaccine
  34. Routine vaccination coverage falls to 13-year low among infants
  35. Speaker: Anti-science surfaces as a threat to nephrology, all health care specialties
  36. Study finds 13% mortality rate among community-living older US adults after major surgery
  37. Study finds International Food Information Council misinforms public on dietary intake
  38. Study shows no detrimental impact of continuing cardiac drugs with advanced CKD
  39. Supply chain disruptions forced 60% of rheumatologists to substitute medications
  40. Top in hem/onc: Tecvayli approval; phase 2 data on prostate cancer therapy
  41. VIDEO: Amniotic membrane useful for dry eye symptoms
  42. VIDEO: Neurology must ‘move the needle’ in promoting health equity
  43. VIDEO: US fertility rates factor into legislation on infertility insurance
  44. Weight gain during adulthood may vary based on obesity phenotypes during adolescence
  45. Worsening disparities observed in enrollment for early metastatic cancer-drug trials